Elucidate the developmental and regulatory heterogeneity of lung carcinoids
Yotam Drier, PhD
Active Projects
Enhancing peptide receptor radionuclide therapy in well-differentiated pancreatic NETs
Brian R. Untch, MD
Epigenetic regulators of intestinal endocrine cells and carcinoid tumors
Qiao Zhou, PhD; Ramesh Shivdasani, MD, PhD
Evaluation of Ac-225 dotatate for treatment of lung carcinoid tumors
David Morse, PhD
Exploring the role of epigenetic dysregulation in PanNET progression
Sita Kugel, PhD
Finding the causes of small intestinal neuroendocrine tumors
Matthew Meyerson, MD, PhD; Eric Nakakura, MD, PhD; Chrissie Thirlwell, MD, PhD
Fluorine-18 labeled MIBG analogues for theranostic applications
David Raffel, PhD
Functionalized silica nanoparticles: development of a combined PET and TAT theranostic agent for NETs
Tara Mastren, PhD
Intra-arterial Peptide Receptor Radionuclide Therapy (IA-PRRT) using 90Y-DOTA-TOC
Thomas Hope, MD
Mapping the gut microbiome in carcinoid syndrome
Hans Hofland, MD, PhD